MedTrace Logo

Follow-up of Children After Stuttering Treatment

NCT00709072 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2010-04-26

No results posted yet for this study

Summary

This study aims to determine the percentage and predictors of stuttering relapse following treatment with the Lidcombe Program. It will also investigate the effectiveness of sending reminder messages to parents to assist in reducing relapse.

Conditions

  • Stuttering

Interventions

BEHAVIORAL

SMS (Short Message Service) reminders

SMS reminders sent every 2 weeks

Sponsors & Collaborators

  • University of Sydney

    lead OTHER

Principal Investigators

  • Mark Onslow, PhD · University of Sydney

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00709072 on ClinicalTrials.gov